Cystic fibrosis

Journal of the Royal College of Physicians of Edinburgh

Volumn 43, Issue 2, 2013, Pages 144-150

  Leitch, A E ^b   Rodgers, H C ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Bronchiectasis; CF services; Cystic fibrosis; Lung transplantation; Management

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PLACEBO; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIOLOGY; BRONCHIECTASIS; BRONCHOSPASM; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA INFECTION; CENTRAL VENOUS CATHETER; CHROMOSOME 7; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISTAL INTESTINAL OBSTRUCTION SYNDROME; DRUG EFFECT; DRUG SAFETY; ERADICATION THERAPY; FEMALE INFERTILITY; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTESTINE OBSTRUCTION; LIFE EXPECTANCY; LIVER DISEASE; LONG TERM CARE; LUNG TRANSPLANTATION; MALE INFERTILITY; NONHUMAN; PATIENT MONITORING; POPULATION RESEARCH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RHINOSINUSITIS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT PLANNING;

BRONCHIECTASIS; CF SERVICES; CYSTIC FIBROSIS; LUNG TRANSPLANTATION; MANAGEMENT;

ADULT; CHILD; CYSTIC FIBROSIS; HEALTH SERVICES; HOSPITAL UNITS; HUMANS; LIFE EXPECTANCY;

EID: 84879071725     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2013.212     Document Type: Article

References (19)

1. Horsley A, Cunningham C, Innes JA (eds). Cystic fibrosis. Oxford: Oxford University Press; 2010. http://dx.doi.org/10.1093/med/9780199582709.001.0001
2. Cystic Fibrosis Trust. UK national charity dealing with all aspects of cystic fibrosis (www.cftrust.org.uk).
3. Cystic Fibrosis Foundation. Organisation searching for a cure for cystic fibrosis (www.cff.org).
4. Ramsey BW, Davies J, McElvaney NG et al. VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365:1663-72. http://dx.doi.org/10.1056/NEJMoa1105185
5. Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-73. http://dx.doi.org/10.1126/science.2475911
6. Collaco JM, Cutting GR. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 2008; 14:559-66. http://dx.doi.org/10.1097/MCP.0b013e3283121cdc
7. McCormick J, Green MW, Mehta G et al. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet 2002; 10:583-90. http://dx.doi.org/10.1038/sj.ejhg.5200850
8. Farrell PM, Rosenstein BJ, White TR et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008; 153:S4-S14. http:// dx.doi.org/10.1016/j.jpeds.2008.05.005
9. Ciofu O, Hansen CR, Hoiby N. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med 2013; 19:251-8. http://dx.doi.org/10.1097/MCP.0b013e32835f1afc
10. Vandenbranden SL, McMullen A, Schechter MS et al. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol 2012; 47:135-43. http://dx.doi.org/10.1002/ppul.21526
11. Lee TW, Brownlee KG, Conway SP et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2:29-34. http://dx.doi.org/10.1016/S1569-1993(02)00141-8
12. Lee TW, Brownlee KG, Denton M et al. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 2004; 37:104-10. http://dx.doi.org/10.1002/ppul.10401
13. Li Z, Kosorok MR, Farrell PM et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005; 293:581-8. http://dx.doi.org/10.1001/jama.293.5.581
14. Doring G, Conway SP, Heijerman HG et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16:749-67. http://dx.doi.org/10.1034/j.1399-3003.2000.16d30.x
15. Ratjen F, Munck A, Kho P et al. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010; 65:286-91. http://dx.doi.org/10.1136/thx.2009.121657
16. Southern KW, Barker PM, Solis-Moya et al. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2012;11:CD002203.
17. Konstan MW, Flume PA, Kappler M et al. Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial. J Cyst Fibros 2011; 10:54-61. http://dx.doi.org/10.1016/j.jcf.2010.10.003
18. Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 2001; 17:295-301. http://dx.doi.org/10.1183/09031936.01.17202950
19. The International Society for Heart and Lung Transplantation. A society that includes basic science, the failing heart and advanced lung disease (https://www.ishlt.org/).